DOI: 10.1016/j.neuron.2015.10.047 year: 2016 study: LIBD_szControl title: BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders. grants: NA authors: journal: Neuron abstract: We outline an ambitious project to characterize the genetic and epigenetic regulation of multiple facets of transcription in distinct brain regions across the human lifespan in samples of major neuropsychiatric disorders and controls. Initially focused on schizophrenia and mood disorders, the goal of this consortium is to elucidate the underlying molecular mechanisms of genetic associations with the goal of identifying novel therapeutic targets. The consortium currently consists of seven pharmac pubmedId: 26687217 entity_name: Neuron 2016 (Pubmed ID 26687217)